Skip to main content
Clinical Trials/CTRI/2025/12/099174
CTRI/2025/12/099174
Not yet recruiting
Phase 3

A Randomised Control Trial comparing the Efficacy and Safety of Atomised Intranasal Dexmedetomidine versus Atomised Intranasal Ketamine for Procedural Sedation in children aged 5-14 years.

Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS)1 site in 1 country180 target enrollmentStarted: January 1, 2026Last updated:

Overview

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS)
Enrollment
180
Locations
1
Primary Endpoint
Depth of Sedation

Overview

Brief Summary

The index Clincal trial "Atomised Intranasal Dexmedetomidine versus Atomised Intranasal Ketamine in Children aged 5-14 years for Procedural Sedation" will be a Randomised Control Trial and is being registered in Clinical Trial Registry of India will be carried out in Department of Paediatrics PGIMS Rohtak with complete adherence to Clinical Trial protocols PI Dr. Kapil Bhalla , Co PI Dr. Bhaviya . The trial results will be avaliable in public domain and any clinical deviation if any, will be duly reported. Total duration of trial will be 9 months from the date of generation of ctri number

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
5.00 Year(s) to 14.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Children aged 5 -14 years having ASA physical status 1 and 2 as per ASA guidelines.

Exclusion Criteria

  • 1-Any known allergy to drug 2- Children having Severe Liver or Renal Insufficiency 3- Severe bradycardia or atrioventricular block above II degree type 2 4- Children whose parents refuse to give consent.

Outcomes

Primary Outcomes

Depth of Sedation

Time Frame: 120 minutes or till clinical recovery.

Secondary Outcomes

  • Time of recovery from sedation(30,45,60,75,90,105,120 minutes)

Investigators

Sponsor
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS)
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Kapil Bhalla

Department of Paediatrics

Study Sites (1)

Loading locations...

Similar Trials